| Literature DB >> 32623144 |
Nikil Patel1, Caroline Banahan2, Justyna Janus2, Mark A Horsfield2, Anthony Cox3, David Marshall2, Jordan Colman3, John Morlese4, David H Evans2, Claire Hannon2, Vincent Egan5, Peter Garrard3, James P Hague6, Emma M L Chung7.
Abstract
OBJECTIVES: This study draws on advances in Doppler ultrasound bubble sizing to investigate whether high volumes of macro-bubbles entering the brain during cardiac surgery increase the risk of new cerebral microbleeds (CMBs), ischemic MR lesions, or post-operative cognitive decline (POCD).Entities:
Keywords: Cardiopulmonary bypass; Cerebral microbleeds; Cognitive outcome; Embolization; MRI brain imaging
Mesh:
Year: 2020 PMID: 32623144 PMCID: PMC7718579 DOI: 10.1016/j.jns.2020.117006
Source DB: PubMed Journal: J Neurol Sci ISSN: 0022-510X Impact factor: 3.181
Fig. 1Bubble diameters estimated for a 55 year old male undergoing aortic valve replacement who had pre-existing cerebrovascular disease (total lesion volume: 1876 mm3) but no pre-existing CMBs. This patient exhibited cognitive decline in 2/8 tests with 10 new CMBs but no new ischemic lesions. Markers denote individual emboli (blue: left MCA events, orange: right MCA events). The vertical axis and marker size reflect estimated bubble diameter [7]. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
Clinical and demographic characteristics of patients undergoing CABG and valve surgery.
| CABG | Valve | ||
|---|---|---|---|
| Men:women | 16:2 | 27:1 | 0.552* |
| Age, y, mean (SD) | 66 (7) | 62 (9) | 0.150† |
| CPB time, mins, mean (SD) | 60 (22) | 101 (57) | 0.006† |
| Mean arterial blood pressure, mmHg, mean (SD) | 64 (9) | 61 (8) | 0.208† |
| Mean haematocrit, %, mean (SD) | 29 (4) | 29 (4) | 0.792† |
| Smoking, n (%) | 8 (44) | 13 (46) | 0.895‡ |
| Treated hypertension, n (%) | 16 (88) | 18 (64) | 0.090* |
| Hypercholesterolemia, n (%) | 18 (100) | 19 (67) | 0.007* |
| Ischemic heart disease, n (%) | 11 (61) | 12 (42) | 0.227‡ |
| Aortic stenosis (mild/severe), n (%) | 5 (27) | 18 (64) | 0.016‡ |
| Pre-existing WMD, cm3, mean (SD) | 739 (1065) | 2047 (5322) | 0.217† |
| No. of old CMBs, n, mean (SD) | 1 (1) | 6 (9) | 0.281† |
| Post-op stroke, n (%) | 2 (11) | 3 (16) | 1.000* |
| Probable CAA, n (%) | 2 (11) | 3 (16) | 1.000* |
Values reported are mean (SD) or count (%) or in a ratio format. *Fisher exact-test, †t-test, ‡χ test. CMB indicates cerebral microbleeds; CPB indicates cardiopulmonary bypass; WMD indicates white matter disease; CAA indicates cerebral amyloid angiopathy.
Comparison of imaging findings, cognitive outcome, and bubble parameters between CABG and valve surgery.
| CABG | Valve | ||
|---|---|---|---|
| New cerebral microbleeds, | 10 (57) | 23 (82) | 0.031⁎ |
| New FLAIR MRI lesions, | 6 (33) | 12 (43) | 0.557⁎ |
| Neuropsychological decline, | 9 (50) | 12 (43) | 0.764⁎ |
| Total emboli, n (IQR) | 859 (625–1442) | 1995 (1077–3127) | 0.004† |
| Emboli: 1 min after removal of AxC, | 6 (2–25) | 39 (7–90) | 0.034† |
| Macro-bubbles: ≥0.1 mm, | 28 (18–108) | 218 (138–505) | 0.001† |
| Shower duration, seconds, | 0 (0–2) | 28 (0–99) | 0.001† |
| Median bubble diameter, μm, | 20 (10−30) | 20 (20–40) | 0.821† |
| Total volume of air, μL, | 0.4 (0–5) | 12.6 (3–26) | 0.005† |
Values reported are median (IQR) Interquartile Range (25th – 75th percentile).*Chi-squared test, †Mann-Whitney U test.
Univariate comparison of age, total number of emboli, number of macro (>0.1 mm) bubbles, number of emboli released following removal of the aortic cross-clamp, shower duration, bubble diameter and volume of air for patients with and without new CMBs, MRI lesions, and cognitive decline.
| No new | New | No new | New | No cognitive decline | Cognitive | ||||
|---|---|---|---|---|---|---|---|---|---|
| Age, | 68 (46–78) | 64 (41–80) | 0.16* | 64 (41–77) | 66 (46–80) | 0.57* | 62 (41–77) | 68 (54–80) | 0.02* |
| Mean CPB time, mins, mean (SD) | 71 (22) | 99 (53) | 0.02* | 98 (58) | 80 (23) | 0.15* | 94 (50) | 87 (47) | 0.59* |
| Total emboli, | 1094 (818–1884) | 1476 (731–2758) | 0.35† | 1073 (667–2070) | 1761 (1087–2480) | 0.13† | 1357 (729–2453) | 1349 (870–2096) | 0.84† |
| Macro-bubbles: ≥0.1 mm, | 157 (20–249) | 169 (35–363) | 0.52† | 131 (26–327) | 171 (112–316) | 0.49† | 194 (55–324) | 132 (22–335) | 0.33† |
| Emboli: 1 min after removal of AxC, | 6.5 (0–38) | 6.0 (0−32) | 0.66† | 8 (0–39) | 46 (11−102) | 0.04† | 12 (4–68) | 23 (2–75) | 0.84† |
| Shower duration, | 0 (0–81) | 10 (0–63) | 0.44† | 2 (0–35) | 11 (0–104) | 0.45† | 10 (0–52) | 0 (0–82) | 0.99† |
| Total volume of air, | 1.7 (0.2–20) | 7 (1.1–21.6) | 0.38† | 5.3 (0.2–18.1) | 6.2 (1.5–28) | 0.37† | 7.4 (1.5–26) | 2.4 (0.2–19) | 0.26† |
| CABG: intra-cardiac procedures | 8:4 | 10:23 | 0.02‡ | 12:16 | 6:12 | 0.52‡ | 9:16 | 9:12 | 0.76‡ |
Values reported are mean (SD) and median (IQR) Interquartile Range (25th – 75th percentile). Age reported as mean (range). CPB; cardiopulmonary bypass, CMBs; cerebral microbleeds, CABG indicates coronary artery bypass grafting; AxC; Aortic cross-clamp. *t-test, †Mann-Whitney U test, ‡Chi-squared test.
Binomial logistic regression analysis for outcomes of new CMBs, new ischemic lesions, and cognitive decline.
| New | New | Cognitive | ||||
|---|---|---|---|---|---|---|
| OR (95% CI) | OR (95% CI) | OR (95% CI) | ||||
| Age, | 0.97 (0.87–1.08) | 0.57 | 0.97 (0.89–1.01) | 0.50 | 1.11 (1.02–1.22) | 0.01 |
| CPB time, | 1.06 (1.01–1.12) | 0.03 | 0.96 (0.93–0.99) | 0.01 | 1.00 (0.98–1.01) | 0.99 |
| Total emboli, | 1.00 (1.00–1.02) | 0.06 | 1.00 (1.00–1.01) | 0.50 | 1.00 (1.00–1.00) | 0.49 |
| Emboli: 1 min after removal of AxC, | 0.95 (0.90–0.99) | 0.03 | 1.03 (1.00–1.10) | 0.02 | 0.98 (0.96–1.00) | 0.19 |
Logistic regression analyses controlling for effects of age and sex. Values presented as OR and 95% CIs. CMBs indicates cerebral microbleeds; CPB; cardiopulmonary bypass; AxC; Aortic cross-clamp.
Left and right hemispheric distribution of new CMBs, new ischemic lesions, and emboli entering the left and right cerebral MCA territories.
| Left cerebral territory | Right cerebral territory | ||
|---|---|---|---|
| Total emboli, | 655 (387–1424) | 671 (370–1130) | 0.51* |
| Estimated volume of air, | 0.02 (0.001–0.01) | 0.02 (0.001–0.01) | 0.71* |
| Emboli 1 min after AxC on, | 7.5 (1−23) | 4.5 (0–16) | 0.09* |
| Emboli 1 min after AxC off, | 8 (2–40) | 6 (0−31) | 0.41* |
| Total MRI FLAIR ischemic lesions, | 0.05* | ||
| Volume of MRI FLAIR lesions, mm3, mean (SD) | 38 (103) | 50 (213) | 0.72* |
| Middle cerebral artery (n) | 15 | 4 | 0.07* |
| Anterior cerebral artery (n) | 1 | 2 | – |
| Posterior cerebral artery (n) | 2 | 1 | – |
| Superior cerebellar artery (n) | 1 | 0 | – |
| Total SWI Cerebral microbleeds | 0.23* | ||
| Middle cerebral artery (n) | 58 | 38 | 0.29* |
| Anterior cerebral artery (n) | 24 | 32 | 0.60* |
| Posterior cerebral artery (n) | 32 | 23 | 0.49* |
| Superior cerebellar artery (n) | 2 | 2 | – |
Values reported are median (IQR) Interquartile Range (25th – 75th percentile) and mean (SD). AxC; Aortic cross-clamp, FLAIR; Fluid attenuated inversion recovery, SWI; Susceptible weighted imaging, *Chi-squared Linear-by-Linear Association test.
Fig. 2Positions of (A) new cerebral microbleeds, and (B) new MRI FLAIR lesions seen in the combined imaging data for all 46 patients. Only 4 new lesions were observed in the right hemisphere MCA territory compared to 14 in the left MCA territory; consistent with fewer emboli identified entering the right MCA in the 1 min following release of the AxC (right: 601 emboli, vs. left 1247 emboli). A similar observation was made for the CMBs, with 38 found in the right MCA territory and 58 in the left MCA territory. Estimated total numbers of bubbles and volume of air entering the MCA territories were similar for both hemispheres.